Alimentary Pharmacology & Therapeutics

Alimentary Pharmacology & Therapeutics is an international journal. It publishes original research and reviews covering the gastrointestinal and hepato-biliary systems. It also covers epidemiology, drug safety, clinical trials, and meta-analyses. This journal is published by Wiley-Blackwell Publishing Ltd, UK. It is indexed in Scopus. Its year-wise impact score is 186.

Alimentary Pharmacology & Therapeutics is an international journal concerned with the effects of drugs on the human gastrointestinal and hepato-biliary systems. The journal accepts original papers, systematic reviews, meta-analyses and randomised controlled trials. AP&T is particularly interested in the translation of research from bench to bedside and in the identification of novel therapeutic targets.

The publisher of this journal is Wiley-Blackwell Publishing Ltd, which is located in United Kingdom. The ISSN of this journal is 02692813, 13652036. The IS0 4 standard abbreviation of this journal is 'Aliment. Pharmacol. Ther.', which is approved for indexing, abstracting, citing and referencing purposes. The Impact Score of this journal is 186 based on Scopus data.

The editorial board of Alimentary Pharmacology & Therapeutics is comprised of some of the best and brightest minds in the field of gastrointestinal pharmacology and therapeutics. They are responsible for ensuring that articles in this journal are of the highest quality, and that they contribute to the field’s growth and development.

The editorial board of this journal is dedicated to providing an open forum for scientists from around the world to share information in a timely manner. They also aim to promote collaboration between researchers from different disciplines in a variety of areas that are vital for the progress of health sciences. The journal has a high impact factor and is published in print and online versions.

Alimentary Pharmacology & Therapeutics (AP&T) is an international journal concerned with the effects of drugs on the human gastrointestinal and hepato-biliary systems, particularly in the context of clinical practice. It publishes original papers, systematic reviews and meta-analyses on all aspects of basic and clinical pharmacology, pharmacokinetics and the therapeutic use of drugs in the alimentary tract.

The journal is also notable for its impact score, which equates to the number of citations received by a given paper. It is also the recipient of the SCImago Journal Rank award for the most citations for the year. Its most prestigious award is the AP&T Prize, which consists of a cash prize and a year’s free subscription to the journal.

If you want your research to have maximum impact, it needs to be published in the right journal. This is done by understanding the scope, or aim, of a journal. Every journal on Taylor & Francis Online has an aims and scope statement, which is very useful for deciding whether a particular journal is the right one to submit your work to.

These range from broad or general journals to interdisciplinary ones that illuminate connections between different fields. They also include journals based on a regional or country focus, such as food science and technology, agriculture, health, environmental sciences, or engineering.

Reviews are an important part of any journal and AP&T is no exception. The journal boasts a robust editorial staff with a track record of publishing high impact research. It is also notable for the number of authors it attracts from across the globe. This makes AP&T the gold standard in its field. It is no wonder that the publication has an impressive list of awards and accolades. This includes the most prestigious accolade of being named as one of the top five most highly cited journals in the gastroenterology and hepatology fields.

Alimentary Pharmacology & Therapeutics (AP&T) is an international journal for the scientific study of the effects of drugs on the human gastrointestinal and hepato-biliary systems, particularly with relevance to clinical practice. It accepts original papers, systematic reviews, meta-analyses and randomised controlled trials.

This journal is indexed and abstracted in Scopus. Its h-index is 186, which means that 186 of the articles published in this journal have been cited at least 186 times. It also meets all the essential criteria of ISO 4 standard. Its ISSN is 02692813, 13652036. You can find more information about this journal at its official website. AP&T uses Mary Ann Liebert's Vancouver reference format.

Comments

Post a Comment

Popular posts from this blog

The Gut Microbiome and Mood Disorders: Recent Developments

Despite the complexity of both the gut microbiota and mood disorders , numerous studies have found a clear correlation between depressive symptoms and gut microbiome changes. This article investigates how the microbiome may be utilized to treat depression and illustrates some of these relationships. Our mental health depends on the composition of our gut flora. Depression has been linked to altered gut microbiome in animal studies. Uncertainty surrounds the function of the human gut microbiome, though. Stress and unbalanced diets may also have an impact on the gut microbiota's makeup. It has been demonstrated that alterations in the microbiota are the cause of stress-induced depressive-like behaviour in mice. Intervention with probiotics can lessen this habit. Folic acid has also been discovered to lessen depressive-like behavior. Depression is known to occur as a result of early stress and inflammation. The gut barrier may be damaged as a result of immunological and endocrine syst...
Read more

Guidelines for the Treatment of Community-Acquired Pneumonia

Community-acquired pneumonia (CAP) is a common cause of death and disability among people living with HIV. CAP is a major public health problem worldwide and has a high mortality rate. The treatment of CAP depends on the type of pneumonia and the cause. For example, bacterial pneumonia requires antibiotics to treat the infection. Antimicrobial therapy is a key component of treatment for community-acquired pneumonia. It involves the use of empirically selected antibiotics that are rapidly started to reduce symptoms, minimize the duration of hospitalization, and prevent complications. The main goals of antibiotic treatment are to identify the pathogen and kill it. The decision to start antimicrobial therapy depends on the type of infection and its severity, as well as the pattern of local antibiotic resistance and other patient-specific factors. The most common pathogens in community-acquired pneumonia are Streptococcus pneumoniae, Haemophilus influenzae, and atypical bacteria such ...
Read more

Mycobacterium lepromatosis causes leprosy

Leprosy is a bacterial infection caused by Mycobacterium lipomatosis. It is a potentially lethal infectious disease. The most prevalent leprosy symptoms are painful blisters and sores on the hands, feet, and entire body. The bacteria Mycobacterium lipomatosis causes leprosy, a chronic infectious disease. It creates lumps and sores on the skin. In addition to these symptoms, it can cause damage to other sections of the body. Other symptoms include kidney, joint, and lymph node inflammation. They can also have an effect on the eyes The skin is the major site of infection for leprosy. The infection can cause nerve damage as it advances. This can result in numbness, weakness, and deformity. Symptoms can appear five to seven years after first coming into contact with an infected person. People who get leprosy are frequently in close, long-term contact with sick people. If you find yourself in this circumstance, seek assistance as soon as possible. Treatment can prevent the disease from spr...
Read more